N umerous maternal cardiovascular adaptations occur during pregnancy, including decreases in uterine vascular resistance, which accommodate dramatic increases in uterine blood flow that facilitates fetal growth.
N umerous maternal cardiovascular adaptations occur during pregnancy, including decreases in uterine vascular resistance, which accommodate dramatic increases in uterine blood flow that facilitates fetal growth. 1 Endothelial nitric oxide synthase (eNOS) is partly responsible for the observed increases in uterine blood flow via production of nitric oxide (NO). 2 Pregnancy is characterized as a physiological state of vasodilation where the endothelial-derived vasodilators PGI 2 3-5 and NO 2, 6, 7 and their respective second messengers cAMP [8] [9] [10] and cGMP 6, [8] [9] [10] [11] [12] [13] are elevated. We reported in the ex vivo uterine artery endothelium (UAendo) model elevated expressions of connexin (Cx) 37, 43, and eNOS during pregnancy. 14 We demonstrated requirement of the gap junction (GJ) protein Cx43 for ATP-induced Ca 2+ bursts associated with eNOS activation both ex vivo 14 and in uterine artery endothelial cells (UAECs) in vitro. 15 Moreover, the normal pregnancy (P)-associated Ca 2+ bursts on ATP stimulation were higher than in the nonpregnant (NP) UAECs, 15 demonstrating that enhanced GJ communication between endothelial cells is crucial for eNOS/ NO-mediated changes during gestation.
Caveolae are specialized protein-rich plasmalemmal invagination sites of signal transduction regulation and are hubs for NO regulation. 16 Within caveolae, eNOS is bound to the scaffolding protein caveolin-1 (Cav-1), maintaining eNOS in an inactive state. 17, 18 Cav-1 and eNOS interactions occur via the caveolin scaffolding domain on Cav-1, which is the same binding region as the eNOS calmodulin-binding domain and is necessary for Ca 2+ /calmodulin-dependent eNOS activation. Some proteins that selectively localize to caveolar microdomains regulate eNOS activity, 16 which is substantially activated with ATP stimulation and require Cx43, but not Cx37, for NO production. 14, 15 Little is known regarding trafficking and partitioning of Cx proteins to caveolar domains, the home for eNOS, and their dynamics with ATP treatment.
We hypothesized that Cx43-mediated GJ function with ATP stimulation is associated with Cx43 repartitioning from the noncaveolar to the caveolar domains. We investigated (1) endogenous levels of ATP, vasodilators (PGI 2 and NO), and their respective cyclic nucleotides (cAMP and cGMP) in NP-UAECs versus P-UAECs; (2) whether the actions of ATP
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on Lucifer yellow dye transfer between P-UAECs specifically involves Cx43 and repartitioning of Cx43 and Cx37 proteins to the caveolar fraction; and (3) the presence of Cx43 and Cx37 proteins relative to other junctional proteins in the caveolar compartment.
Methods
For detailed methods, see online-only Data Supplement.
Cell Preparation/Culture
Protocols were approved by the University of Wisconsin-Madison Animal Care Committee. 19 NP-UAECs and P-UAECs were isolated and cultured from nonpregnant (n=6-10) and late pregnant (n=6-10) ewes. 19 Passage 4 UAECs (≈90% confluence) were (1) transferred to 96-well plates for experimental treatments, and supernatant medium was used for enzyme immunoassays, (2) transferred to chamber slides for experimental treatments, immunofluorescence, and Lucifer yellow dye transfer studies, or (3) lysed for Western analyses.
Measurements of Basal ATP, PGI 2 , cAMP, NOx, and cGMP Levels
We used ViaLight Plus High Sensitivity Cell Proliferation and Cytotoxicity Assays to measure ATP. 20 PGI 2 (measuring the stable nonenzymatic hydrolysis product, 6-keto-PGF1α), 3 cAMP, and cGMP production levels were determined using EIA kits. Total NO was measured using HPLC, NOx Analyzer (ENO-30).
Lucifer Yellow Dye Transfer
P-UAECs were grown on Laboratory-Tek II chamber slides with glass coverslips and treated (30 min) with ATP (100 μmol/L) in the absence or presence of Cx peptide inhibitors (300 μmol/L) for Cx43 (43, 37)Gap27, Cx37 (40, 37)Gap26, or scramble control peptide (43,37 scramble)GAP27. UAECs were scraped at several sites with a razor and incubated with 0.05% Lucifer yellow and tetramethylrhodamine dextran 15 and viewed by fluorescent microscopy (triplicates). Areas of dye spread (fluorescent areas) were quantified using ImageJ software.
Immunofluorescence Confocal Microscopy for Cav-1 and Cx43
Immunofluorescence confocal microscopy for Cav-1 and Cx43 was performed in the absence and presence of ATP (100 μmol/L; 30 minutes) as described previously.
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Caveolar Isolation
Caveolar isolation was performed as described previously.
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Proteomic Analysis
Peptides were analyzed by nano-liquid chromatography-tandem mass spectrometry (LC-MS/MS) as described previously. 16 
Western Analyses
Western analyses performed on whole cell lysates 19 used antibodies for Cav-1 (1:10 000), Cx43 (1:3000), and Cx37 (1:5000), secondary antibodies for anti-rabbit or anti-mouse, and detection using enhanced chemiluminescence and HyperFilm enhanced chemiluminescence (GE Healthcare Bio-Sciences Corp, Piscataway, NJ), with β-actin as a loading control.
Statistical Analysis
Data are presented as means±SEM fold of control. Group differences were analyzed using 1-way or 2-way analysis of variance (SigmaPlot 11) followed by post hoc multiple pairwise comparisons StudentNewman-Keuls/Bonferroni tests. Significance was established a priori at P<0.05.
Results
Basal ATP, PGI 2 , cAMP, NOx, and cGMP Levels
Compared with NP-UAECs, P-UAECs had more (P<0.05) endogenous ATP (1.9-fold), and the endothelial-derived vasodilators PGI 2 (2.5-fold; P<0.05) and NOx (1.4-fold; P<0.05) were elevated along with proportional increases of their respective second messengers cAMP (2.6-fold; P<0.001) and cGMP (1.8-fold; P<0.05, Table) .
Cx43, but Not Cx37, GJs Mediate Lucifer Yellow Dye Transfer
Lucifer yellow dye transfer in P-UAECs was elevated by ATP treatment, a response abrogated by GAP27 peptide, but not by GAP26 (Figure 1 ). Control-scrambled peptide for GAP27 had no effect on dye transfer with ATP treatment, indicating functional importance of GJ intercellular communication (GJIC) via Cx43, not Cx37.
Cx43, but Not Cx37, Colocalizes With Cav-1
In P-UAECs, confocal microscopy revealed subcellular locations of Cx43 (red) with the marker for the caveolae Cav-1 (green). We observed distinct ATP-mediated repartitioning and colocalization between Cx43 and Cav-1 (merge yellow) in both the caveolar and noncaveolar domains (Figure 2 ).
Proteomic Analysis of Caveolar Cx43 and Cx37
We observed the presence of Cx43, but not Cx37 (not shown), in the P-UAEC caveolar fraction. Representative MS/MS spectra of Cx43 illustrate Y ion series assignment showing peptide fragment ions from the C terminus ( Figure 3A) . B ion series from the N terminus confirms Cx43 peptide assignment. We further observed an excellent Sequest cross-correlation score for Cx43 peptide sequences and low parent mass error of −0.79. Proteomic analysis did not identify Cx37 in P-UAEC caveolar fractions. The identified Cx43 peptide sequence had 17% coverage, with 4 unique peptides, 4 unique spectra, and 5 total spectra ( Figure 3B ).
Caveolar Domain-Specific Localization of Cx43, but Not Cx37
Using western analysis, we determined the presence of Cx43 in both P-UAEC caveolar and noncaveolar domains. ATP Figure 4A ). Low levels of Cx37 were observed in the caveolar domain. Although
Cx37 was predominately located in the noncaveolar domain, treatment with ATP did not significantly alter Cx37 distribution in either the caveolar or the noncaveolar domains ( Figure 4B ). Thus, western analysis confirmed in a semiquantitative fashion the proteomic analysis showing the presence mainly of Cx43 (not Cx37) in the caveolar domain even after ATP stimulation in P-UAECs.
Cav-1 Is Expressed In Vivo in UAendo and Displays Linear Correlations With Phosphorylated and Total eNOS
We previously reported in ex vivo samples of UAendo substantial local unilateral pregnancy-associated increases in Cx37, Cx43, and phosphorylation of eNOS associated with in vivo rises in uterine blood flow and shear stress. 14 Herein, we reexamined those UAendo blots for the presence of Cav-1 and observed substantial increases in Cav-1 during pregnancy that was limited only to the UAendo ipsilateral to the gravid uterine horn ( Figure S1 in the online-only Data Supplement). We observed significant correlations between UAendo Cav-1 and P 635 eNOS ( Figure S2 ; r=0.57) and total eNOS ( Figure S3 ; r=0.62), providing additional physiological in vivo 14 evidence supporting our current in vitro data showing that Cx43 association with Cav-1 facilities GJ function ( Figure 1 ) and eNOS activation.
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Discussion
We report herein that compared with NP-UAECs, P-UAECs exhibit higher endogenous ATP levels and elevations in the potent endothelial vasodilators PGI 2 and NOx and proportional elevations in their second messengers cAMP and cGMP. P-UAEC elevations of ATP and these cyclic nucleotides are novel observations and are consistent with other studies in vivo. 9, [11] [12] [13] 19 These observations demonstrate a vasodilatory phenotype of UAECs for pregnancy-specific programming, with elevations in basal PGI 2 3,19 and NO 2, 19 production as well as key uterine artery endothelial-derived proteins, enzymes, and receptors. 3, 8, 19 We previously showed ex vivo in uterine artery explants that PGI 2 was responsible for the cAMP production and NO for cGMP production.
14 Elevations in these endothelial vasodilators are responsible for proportional inductions of the respective elevated levels of cAMP 8, 13, 19 and cGMP. 8, 13, 19 Signaling of cyclic nucleotides are further implicated in the formation and assembly of GJs through posttranslational modifications of Cx43. 22 Thus, this signaling process involves a feed-forward loop between ATP, cyclic nucleotides, and Cx43-mediated GJIC to establish this pregnancy-specific vasodilatory phenotype.
GJ proteins Cx43 and Cx37 are the most prevalent Cx subtypes observed in the UAendo and are elevated during pregnancy. 14 We directly showed that ATP increases GJIC functionality, which is solely Cx43-mediated (GAP27-inhibited), and that Cx37 is not involved because GAP26 peptide did not alter Lucifer yellow dye transfer. These data are consistent with cultured P-UAECs 15 and ex vivo 14 studies using these same peptide inhibitors where Cx43, but not Cx37, was required for Ca 2+ -associated ATP-mediated rises Figure 1 . ATP-induced Lucifer yellow dye transfer is Cx43-, not Cx37-, mediated. Representative fluorescence dye microscopy images after treatment with 100 μmol/L ATP (30 minutes) and inhibitory and control GAP peptides in pregnant uterine artery endothelial cells (P-UAECs). A, Left, Tetramethylrhodamine (TMR) dextran staining at the cell membrane. TMR dextran is too large to pass through gap junctions (GJs) and serves as a measure of cell damage at the wounding site and a marker for Lucifer yellow entry. Middle, Lucifer yellow dye that passes through GJs starting at the wound site into adjacent cells. Right, Merged photo of TMR dextran and Lucifer yellow dye images. P-UAECs treated with ATP displayed increased Lucifer yellow dye transfer. GAP27, but not GAP26, or scrambled control peptide abrogated ATP-mediated increases in Lucifer yellow dye transfer. ----denotes wound site, and |← denotes distance the Lucifer yellow dye traveled from the wound site. B, Fold of control quantification of the fluorescence area in dye-coupled cells. *Increase (P<0.05) in P-UAEC treatment groups compared with control (n=3). Cx indicates connexin. . These studies highlight that Cx43-mediated GJIC and NO biosynthesis are interdependently linked for vasodilatory function and that the relationship between Cx43 and NO is surmised by studies showing that both Cxs and eNOS influence the expression and activity of each other in association with their interaction with Cav-1 [23] [24] [25] ( Figures S2 and S3 ). We present confocal microscopy data showing an increase in the rapid ATP-induced colocalization of Cx43 and Cav-1 at the plasma membrane. These data are consistent with studies showing that Cav-1 and Cx43 both colocalize 26, 27 and translocate from the golgi to the plasma membrane. Reduction of Cav-1 in endothelial cells directly affected Cx location in the plasma membrane and formation and function of GJs. 27 Caveolae localize to myoendothelial GJs, 28 and ATP-stimulated translocation of Cx43 may increase transmission of signaling molecules across myoendothelial GJs connecting endothelial and vascular smooth muscle cells. It is unclear how ATP functions to target the Cx43 specifically to the caveolae. Schubert et al 26 examined in an unstimulated state how Cxs are specifically targeted to lipid raft domains to interact with Cav-1 in human embryonic kidney cells. Our work using caveolar-enriched fractions directly corroborates and visualizes their suppositions as they demonstrated that Cx43 colocalizes, cofractionates, and coimmunoprecipitates with Cav-1. 26 However, we further show that Cx43 partitioning into caveolar fractions change with ATP treatment, demonstrating the rapid and dynamic nature of these events as they relate to NO production. We also show specific Cx43 responses relative to Cx37, especially for ATP-induced Ca 2+ -mediated activation of eNOS. 14, 15 On stimulation with the Ca 2+ mobilizing physiological agonist ATP, uterine endothelial Cx43 translocates to the caveolar compartment of cell membranes where they interact with and activate eNOS to facilitate NO rises.
Cx37 function in noncaveolar domains remains unclear. Proteomic analysis revealed the presence of Cx43, but not Cx37, in the caveolar proteome. Yet, Cx37 was predominately located in the noncaveolar domain and was unaltered by agonistic ATP treatment. We do know that Cx37 is not intimately involved in ATP-stimulated NO production. 17, 18 We interpret this lack of Cx37 levels in the caveolar domain to more fully explain why the GAP26 in P-UAECs 18 or UAendo, 17 which blocks Cx37, had no effect on ATPmediated Ca 2+ burst-associated rises in NO production. Moreover, others reported in microvascular endothelial cells that Cav-1 did not colocalize with Cx37, 29 which is fully consistent with our study.
In conclusion, UAECs exhibit pregnancy-specific endogenous increases in ATP levels and a vasodilatory phenotype associated with elevations in PGI 2 -cAMP and NO-cGMP production. Consistent with the model described in Figure  5 , ATP-stimulated increases in Lucifer yellow dye transfer occurs primarily via Cx43 by inducing increased Cx43 levels and cAMP-mediated GJ colocalization with Cav-1 in caveolar domains where eNOS resides. This rapid temporal and spatial colocalization of Cx43 to the caveolae demonstrates the need for GJIC and quick cell signaling in gestation to maintain rises in intracellular Ca 2+ for increased NO production. 17, 18 Cx37 was predominately located in the noncaveolar domain and was unaltered by ATP stimulation, but may have a role in myoendothelial GJs with underlying vascular smooth muscle. Our data are suggestive that the pregnancyspecific programming of UAECs at the level of signaling involves enhanced Cx43 function and localization within the caveolae to rapidly increase the endothelial synthesis of NO to maintain uterine blood flow required for healthy fetal growth and survival.
Perspectives
The specific mechanisms by which GJs regulate vascular tone through the modulation of vasodilatory pathways during pregnancy are unclear. However, in vivo and ex vivo studies have shown that these vasodilatory pathways involve the requirement of a specific GJ protein, Cx43, to regulate ATPinduced eNOS activation and NO production that is Ca 2+ -mediated. 14, 15 These endothelial actions of ATP are mediated through caveolar microdomains that possess protein machinery for eNOS-NO regulation. 21 We noted that ATP stimulates rapid Cx43 repartitioning from the noncaveolar to the caveolar domain where eNOS resides and is activated for NO production. Delineating mechanisms establishing the vasodilatory phenotype of pregnancy provides greater understanding of specific mechanisms functioning abnormally in the pathophysiology of vascular diseases, such as hypertension and preeclampsia.
Expanded Methods
UAEC Isolation:
The University of Wisconsin-Madison research animal care committees of the Medical School and the College of Agriculture and Life Sciences approved all procedures and protocols for animal handling and experiments which follow the recommended American Veterinary Medicine Association guidelines for humane treatment and euthanasia of laboratory farm animals. Uterine arteries were obtained from mixed Western breed nonpregnant sheep (n = 6-10) and pregnant ewes at 120-130 days gestation (n=6-10) during nonsurvival surgery as previously described 1 . Uterine arteries were dissected free of connective tissue, fat, and veins. Arteries were rinsed free of blood using medium 199 before tying off arterial branches, clamping off the larger diameter end, and inflating with medium 199 containing 5 mg/ml collagenase B (Roche Molecular Biochemicals) and 0.5% BSA through a three-way stop cock tap. Digestion was allowed to proceed at 37 C for 55 min before flushing the collagenase solution and endothelial cell sheets from the inner surface of the vessel.
Measurements of Basal ATP, PGI2, cAMP, NOx, and cGMP levels ATP: As part of the validation of cell number and cell viability assays for another study, we utilized the ViaLight Plus High Sensitivity Cell Proliferation and Cytotoxicity Assay to measure ATP (Lonza Inc., Rockland, ME) 2 . Briefly after 24 hour starvation in 96-well plates, luteal NPUAECs (n=6 each run in duplicate) and P-UAECs (n=6 each run in duplicate) were exposed to Lysis Reagent (10 minutes) to extract ATP from cells and then incubated with ATP Monitoring Reagent Plus for 2 minutes to generate luminescent signal. Plates were read using Synergy HT Multi-Mode Microplate Reader to determine luminescence and results expressed in Relative Light Units (RLU) as fold increases over luteal controls after subtracting the value of the blank against an ATP standard curve.
PGI2, cAMP and cGMP ELISA Assay: Luteal NP-UAECs (PGI2 & cAMP, n=10 ; cGMP n=6 each run in duplicate) and P-UAECs (PGI2, cAMP, and cGMP n=10 each run in duplicate) were plated in 6-well plates, serum-starved for 24 hours, followed by a 30 minutes incubation with Modified Ca 2+ free Krebs Buffer. Media from individual 6-well plates were collected for the quantitative determination of PGI2
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, cAMP, and cGMP levels by using enzyme immunoassay kits (Cayman Chemical, Ann Arbor, MI).
NOx: Luteal NP-UAECs (n=6 each run in duplicate) and P-UAECs (n=6 each run in duplicate) were plated in 6-well plates, serum-starved in endothelial basal media (EBM), and media changed to Modified Ca 2+ free Krebs Buffer containing HEPES 25mmol/L, NaCl 125mmol/L, KCl 5mmol/L, MgSO4 7H2O 1mmol/L, KH2PO4 1mmol/L, Glucose 6mmol/L and adjusted with to pH=7.4 for 30 minutes, as previously described 3 . Media was collected and stored in -80C until analyzed for NO metabolites, nitrate and nitrite. NO production was measured using NOx Analyzer (ENO-30) and Insight autosampler (AS-700) from Eicom Corporation.
Lucifer Yellow Dye Transfer:
To study cell-cell communication, cells were grown to confluence on Lab-Tek II chamber slides with glass coverslips (Thermo Scientific) and treated for 30 minute treatment with ATP alone or with respective peptide inhibitors; (43, 37)Gap27 (300 μmol/L), a Cx43 specific extracellular loop mimetic peptide, or (40, 37)Gap26 (300 μmol/L), a Cx40 and Cx37, specific mimetic peptide, or a scramble control peptide (43,37 scramble) GAP27 (300 μmol/L) as described previously 5 . Cells were scraped at several sites with a sterile razor blade and incubated for 10 min in the dark at room temperature with 0.05% lucifer yellow and tetramethylrhodamine (TMR) dextran (3KDa) (Molecular Probes) dissolved in Modified Ca 2+ free Krebs buffer (125 mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L MgSO4, 1 mmol/L KH2PO4, 6 mmol/L glucose, 2 mmol/L CaCl2, and 25 mmol/L HEPES, pH 7.4) containing an additional 50 μmol/L ethylene glycol tetraacetic acid (EGTA) 6 . Cells were rinsed four times with Ca 2+ -free Krebs/50 μmol/L EGTA buffer and images were captured using a Nikon Eclipse TE 2000U inverted fluorescence microscope and analyzed with Spot Advanced software (v.4.6, Diagnostic Instruments) to determine the amount of lucifer yellow dye ("green" cell layers) but not TMR red dye ("red" cell layers) that moved through gap junctions from neighboring loaded cells. Images were quantified using ImageJ software. Experiments were repeated in triplicate per setting.
Immunofluorescence confocal microscopy for Cav-1 and Cx43: Immunofluorescence confocal microscopy was performed as described previously 7 . UAECs were washed twice with ice-cold PBS and fixed for 15 min with 3% paraformaldehyde. Fixed cells were rinsed (3 min) with a 50-mmol/L glycine solution, permeabilized with 0.1% Triton-X, blocked (30 min) with goat serum, and incubated (60 min) with primary antibodies for, Cx43, and Cav-1. Subsequently, cells were incubated (30 min) with secondary antibodies Alexa Fluor 488/555 anti-mouse or anti-rabbit IgG. Scanning was performed with a radiance 2100 MP Rainbow confocal/multiphoton laser scan microscope system (Bio-Rad Hercules, CA).
Caveolar isolation and peptide digestion:
UAECs were grown to approximately 80% in T75 flasks, treated with ATP, and pooled for caveolar isolation using discontinuous sucrose density gradient centrifugation as described previously [7] [8] [9] . Cells were collected in a 0.5 ml sodium carbonate buffer (pH =11) containing phosphatase inhibitors and protease inhibitors. A light scattering band confined to the 5-35% sucrose interface was enriched with caveolar membranes and the cell suspension was homogenized and sonicated on ice. Protein concentration was measured and adjusted to same protein loading amounts between samples using the sodium bicarbonate buffer. Proteins from aliquots of caveolar fractions were extracted by precipitation with equal volume of 15% ice trichloroacetic acid, incubated 1hr on ice, and centrifuged for 10 minutes (4 °C) at 16,000 x g. Pelleted proteins were re-solubilized and denatured in 10μl of 6M Urea and 100mM NH 4 HCO 3 for 10 min then diluted to 50 μl for digestion with 1μl of 25mM DTT, 7 μl acetonitrile, 22 μl MilliQ water and 10 μl of 20 ng/μl trypsin (Trypsin Gold, PROMEGA Inc.) in 25 mM NH 4 HCO 3 (Ramadoss 2010) . Following digestion for 2 hrs at 42°C, 10 μl cells were incubated with trypsin solution at 37 °C. The reaction was terminated by acidification with 2.5% trifluoroacetic acid.
Proteomic Analysis: Peptides were analyzed by nanoLC-MS/MS using the Agilent 1100 nanoflow system (Agilent, Palo Alto, CA) connected to a hybrid linear ion trap-orbitrap mass spectrometer (LTQ-Orbitrap, Thermo Fisher Scientific, San Jose, CA) equipped with a nanoelectrospray ion source, as described previously, (Koch 2010). Capillary HPLC was performed using an in-house fabricated column with integrated electrospray emitter (Martin 2000) except for the usage of a 360 μm OD (OD = Outer Diameter) x 75 μm ID (ID = Inner Diameter) fused silica tubing. The column was packed with 5 μm C 18 particles (Column Engineering, Ontario, CA) to approximately 12 cm. Samples were loaded (8 μl) and desalted using a trapping column in line with the autosampler (Zorbax 300SB-C18, 5 μM, 5 x 0.3 mm, Agilent). HPLC solvents were as follows: Loading: 1% (v/v) ACN, 0.1M acetic acid; A: 0.1M acetic acid in water, and B: 95% (v/v) acetonitrile, 0.1M acetic acid in water. Samples were loaded and desalted at 10 μL/min with the loading solvent delivered from an isocratic pump. Gradient elution was performed at 200 nL/min and increasing %B in A of 0 to 40 in 200 minutes, 40 to 60 in 20 min, and 60 to 100 in 5 min. The LTQ-Orbitrap was set to acquire MS/MS spectra in data-dependent mode as follows: MS survey scans from m/z 300 to 2000 were collected in profile mode at a resolving power of 100,000. MS/MS spectra were collected on the five most-abundant signals in each survey scan. Dynamic exclusion was employed to increase dynamic range and maximize peptide identifications. This feature excluded precursors up to 0.55 m/z below and 1.05 m/z above previously selected precursors. Precursors remained on the exclusion list for 15 secs. Singly-charged ions and ions for which the charge state could not be assigned were rejected from consideration for MS/MS. Tandem mass spectra were extracted, charge state deconvoluted and deisotoped by BioWorks version 3.1. Raw MS/MS data were searched against NCBI non-redundant Bos taurus amino acid sequence database (Bos_taurus_020209; 64765 entries; for trypsin digestion) using in-house Sequest search engine (ThermoFinnigan, San Jose, CA; version 28, rev. 13) with a fragment ion mass tolerance of 0.50 Da, a parent ion tolerance of 2.5 Da and methionine oxidation as variable modification [10] [11] [12] . Scaffold (version 2.06.02; Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications. Peptide identifications were accepted if they could be established at a probability of P < 0.05 as specified by the Peptide Prophet algorithm 13 . Protein identifications were accepted if they could be established at probability P < 0.05 and contained at least 'two' identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm and proteins that contained similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy the principles of parsimony. An estimate of protein enrichment was determined by using a normalized spectral count method previously described and validated 14 . Counted spectra are provided by Scaffold in five different forms: 1) unique peptides, 2) unique spectra, 3) number of identified spectra and 4) percent of total spectra, and 5) unweighted spectral counts 15 . In addition to these, the Scaffold software version 2.06.02 provides a more sophisticated parameter called quantitative value to estimate protein enrichment and is derived from averaging the spectrum counts across biosamples within groups, followed by averaging the spectral counts between groups, and then multiplying the spectrum counts in each group by the average divided by the individual biosample. Commonly observed impurities (keratins) and any protein (hemoglobin and unnamed protein) not found in standard endothelial caveolar analyses were not included for categorization.
Western Analysis: Protein samples (20 µg/lane) were separated by a 4-20% Tris-HCl gel electrophoresis and transferred to a PVDF membrane as previously described 1 . Proteins (equal volume) were boiled for 2 minutes, followed by electrophoresis on a 4-20% Tris-HCl gel (BioRad; Hercules, CA) for 90 min at 150V. Separated proteins were then electrically (60 minutes, 100V) transferred to a PVDF membrane. For in vitro studies, Cx37 (1:5000; Alpha Diagnostic; San Antonio, TX) and Cx43 (1:3000; Sigma Corporation; St. Louis MO) proteins were detected and non-specific binding was blocked with 5% fat-free milk in TBST (50 mmol/L Tris-HCl, pH 7.5, 0.15 mol/L NaCl, 0.05% Tween-20) for 2 hours at room temperature. Utilizing caveolar and non-caveolar fractionated proteins as previously described 9 , caveolin-1 (1:10000; Cell Signaling; Beverly MA) was used as a loading control for the caveolar domain; beta-actin (1:3000; Cell Signaling; Beverly, MA) was used as a loading control for the non-caveolar domain. For ex vivo studies, we re-probed UAendo membranes for cav-1. These membranes were previously used for proteins collected from the luteal, follicular, unilateral pregnant, and pregnant ewes 16 , where we performed western analysis for eNOS S635, and total eNOS expression. The membrane was incubated with appropriate amounts of primary antibody in TBST + 1% BSA overnight at 0 ˚C. Following five washes (1 x 5, 1 x 15, 3 x 5 minutes) with TBST, the membrane was incubated with either anti-rabbit (1:3000; Cell Signaling; Beverly, MA) or anti-mouse (1:300; GE Healthcare; Piscataway, NJ) HRP conjugated IgG for 1 hour. The membrane was again washed with TBST as stated above, and bound antibodies were detected with the ECL (Thermo Scientific; Rockford, IL) or ECL+ (GE Healthcare; Piscataway, NJ) reagents according to the manufacturer's instructions. Results were quantified by scanning densitometry.
Supplemental Results & Discussion
Cav-1 is expressed in vivo in UAendo
We previously reported in ex vivo samples of UAendo 16 , that the substantial rises in UBF and shear stress in pregnancy are pregnancy associated with concurrent increases in Cx37, Cx43, P 635 eNOS, and total eNOS and that using a unilateral model of pregnancy, these changes occurred in the uterine vasculature ipsilateral to the gravid horn. For the current study we wanted to provide an in vivo physiologic perspective regarding changes in Cav-1 relative to eNOS during thee physiologic states of high and low UBF and estrogen. Therefore using the same protein western blots; we further examined UAendo for the presence of the main caveolar scaffolding protein, Cav-1 ( Figure S-1) . Compared to the nonpregnant luteal control, we report that UAendo Cav-1 is significantly (P<0.01) elevated 3.3 ± 0.8 fold in the unilateral gravid horn as well as 4.0 ± 0.8 fold in the control pregnant group. UAendo Cav-1 trended to be higher (P = 0.2; 2.1 ± 0.8 fold of luteal), but did not reach statistical significance. Cav-1 in the unilateral non-gravid group was not different (1.2 ± 0.4 fold) when compared to the luteal group. Thus we demonstrate using this unilateral pregnant ovine model 17 , that restricting pregnancy to a single uterine horn restricts increases in Cav-1 locally only in the ipsilateral, not contralateral, uterine UAendo. These data, along with our previous eNOS and Cx43 observations 16 clearly suggest in vivo that Cav-1 is indeed critical to the Cx43 facilitated NO production during pregnancy required for a healthy fetal growth and survival.
Linear Correlation between Caveolin-1, phosphorylated eNOS, and total NOS
We observed a significant linear correlation between UAendo Cav-1 and both P 635 eNOS (Figure S-2 ; r=0.57) and total eNOS (Figure S-3; r=0.62 ). These data clearly show that the unilateral presence of the fetoplacental unit induces rises in Cav-1, Cx43, and eNOS levels as their expression in the unilateral non-gravid horn was similar to that of a nonpregnant ewe. These increases in Cav-1 could be related to the unilateral rises in uterine artery shear stress or local secretion of hormones from the placenta such as estrogen or angiogenic growth factors. Estrogen has been shown to elevate Cav-1 expression in endothelial cell cultures from various vascular beds 18, 19 . Moreover, the follicular phase is associated with a rise in the estrogen to progesterone ratio and rises in UBF 20, 21 .
Although eNOS is elevated in UAendo in follicular compared to luteal phase, we only observed a modest trend for rises in UAendo Cav-1 in the follicular phase. This may be due to the fact that a previous study of ours indicated that prolonged estrogen treatments decreased Cav-1 expression in UAendo 22 . These ex vivo data coupled with our previous in vitro 5, 7 studies demonstrate that during pregnancy, physiologic rises in vascular Cx43 and eNOS, located in the caveolar compartment, are associated with rises in Cav-1 where they interact in order to facilitate NO-mediated rises in UBF.
